Related by context. Frequent words. (Click for all words.) 70 Panzem R 69 Pivotal Phase III 68 VALSTAR 68 Application BLA 67 SANCTURA R 67 MKC# 67 refractory chronic lymphocytic 66 FDA Accepts 66 ANYARA 66 Phase III Clinical Trial 65 Drug Candidate 65 forodesine 65 Kuvan R 64 Phase III Trial 64 ZALBIN 64 R bortezomib 64 Cetrorelix 64 NEBIDO 64 Ixempra 64 Application MAA 64 Nexavar ® 64 Pivotal Phase 64 R sorafenib tablets 64 Presents Positive 63 liposomal formulation 63 Completes Enrollment 63 phenylalanine ammonia lyase 63 HCV protease inhibitor 63 metastatic castration resistant 63 Onalta 63 Daclizumab 63 Factor VIIa 63 Initiate Phase 63 Recombinant Human 63 Biologics License Application 63 Voreloxin 63 Urocidin 63 Icatibant 62 application sNDA 62 injection USP 62 Copegus R 62 Proxinium TM 62 MEK inhibitor 62 Extended Release Tablets 62 Orphan Drug status 62 apaziquone 62 Advancing Drugs 62 Patient Enrollment 62 Entereg R 62 multi kinase inhibitor 62 II Clinical Trial 62 BEMA TM Fentanyl 62 Microplasmin 62 Extended Release 62 pseudobulbar affect PBA 62 phase IIb clinical 61 Clinical Trial Results 61 Generic Version 61 Metastatic Melanoma 61 Phase IIb trials 61 Belinostat 61 Rebif ® 61 Pivotal Trial 61 sodium Injection 61 anticancer compound 61 Phase 2b clinical trials 61 DDP# 61 inflammation autoimmune diseases 61 Clofarabine 61 Irinotecan 61 Clevudine 61 proteasome inhibitor 61 Biologics License Application BLA 61 Amrubicin 61 Pirfenidone 61 Orphan Drug designation 61 Surgical Adhesive 61 Epratuzumab 61 subcutaneous formulation 61 Aerosurf 61 Aloxi R 61 Medarex logo 61 Tesetaxel 61 Lenalidomide 61 Gemzar ® 60 Orphan Drug Designation 60 MOZOBIL 60 metastatic hormone refractory 60 TRANSDUR Sufentanil 60 humanized anti 60 submitted Biologics License 60 INCB# [001] 60 SANCTURA XR 60 cutaneous T cell 60 novel orally administered 60 advanced carcinoid 60 REPLAGAL 60 Eligard R 60 Vandetanib 60 Celsion Corporation 60 6R BH4